SE9703379D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9703379D0 SE9703379D0 SE9703379A SE9703379A SE9703379D0 SE 9703379 D0 SE9703379 D0 SE 9703379D0 SE 9703379 A SE9703379 A SE 9703379A SE 9703379 A SE9703379 A SE 9703379A SE 9703379 D0 SE9703379 D0 SE 9703379D0
- Authority
- SE
- Sweden
- Prior art keywords
- sub
- alkyl
- substituted
- intermediates
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
PT98944379T PT1025094E (pt) | 1997-09-18 | 1998-09-09 | Derivados de indano substituidos |
AU91934/98A AU734583B2 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
CA002303839A CA2303839A1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
DE69825912T DE69825912T2 (de) | 1997-09-18 | 1998-09-09 | Substituierte indanderivate |
SI9830708T SI1025094T1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
AT98944379T ATE274502T1 (de) | 1997-09-18 | 1998-09-09 | Substituierte indanderivate |
EP98944379A EP1025094B1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
ES98944379T ES2224429T3 (es) | 1997-09-18 | 1998-09-09 | Derivados de indano sustituido. |
JP2000511758A JP4020183B2 (ja) | 1997-09-18 | 1998-09-09 | 置換されたインダン誘導体 |
PCT/SE1998/001605 WO1999014207A1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
US09/171,575 US6548498B1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
US10/339,477 US20030144291A1 (en) | 1997-09-18 | 2003-01-09 | Substituted indan derivatives |
US10/807,918 US20050096326A1 (en) | 1997-09-18 | 2004-03-24 | Substituted indian derivatives |
US11/543,250 US7439356B2 (en) | 1997-09-18 | 2006-10-03 | Substituted indan derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9703379D0 true SE9703379D0 (sv) | 1997-09-18 |
Family
ID=20408299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Country Status (11)
Country | Link |
---|---|
US (4) | US6548498B1 (sv) |
EP (1) | EP1025094B1 (sv) |
JP (1) | JP4020183B2 (sv) |
AT (1) | ATE274502T1 (sv) |
AU (1) | AU734583B2 (sv) |
CA (1) | CA2303839A1 (sv) |
DE (1) | DE69825912T2 (sv) |
ES (1) | ES2224429T3 (sv) |
PT (1) | PT1025094E (sv) |
SE (1) | SE9703379D0 (sv) |
WO (1) | WO1999014207A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
JP4280067B2 (ja) | 2001-01-16 | 2009-06-17 | アストラゼネカ・アクチエボラーグ | 治療用ヘテロ環式化合物 |
US7026314B2 (en) | 2001-01-16 | 2006-04-11 | Astrazeneca Ab | Therapeutic chromone compounds |
WO2006088246A1 (ja) * | 2005-02-18 | 2006-08-24 | Takeda Pharmaceutical Company Limited | Gpr34受容体機能調節剤 |
US8306918B2 (en) | 2005-10-11 | 2012-11-06 | Apple Inc. | Use of media storage structure with multiple pieces of content in a content-distribution system |
US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
RU2011117935A (ru) * | 2008-10-15 | 2012-11-27 | Нитто Денко Корпорейшн | Способ получения конъюгатов полиглутаматов |
WO2011075483A1 (en) * | 2009-12-16 | 2011-06-23 | Nitto Denko Corporation | Controlled synthesis of polyglutamic acid |
GB201002563D0 (en) | 2010-02-15 | 2010-03-31 | Cambridge Entpr Ltd | Compounds |
US9815768B2 (en) | 2014-02-28 | 2017-11-14 | Sumitomo Chemical Company, Limited | Method for producing 2-(halogenomethyl)-3-methylnitrobenzene |
EP3230255B1 (en) * | 2014-12-09 | 2020-03-18 | Ezekiel Golan | Binge behavior regulators |
CN114903134A (zh) * | 2014-12-09 | 2022-08-16 | 以西结·戈兰 | 酒精饮料替代品 |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918282A (en) * | 1958-02-07 | 1959-12-22 | Waterval William | Health exercising devices |
WO1994021619A1 (en) * | 1993-03-16 | 1994-09-29 | Pfizer Inc. | Naphthalene derivatives |
US5914349A (en) * | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
EP1259484B1 (en) * | 2000-01-18 | 2005-05-18 | Novartis AG | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
-
1997
- 1997-09-18 SE SE9703379A patent/SE9703379D0/sv unknown
-
1998
- 1998-09-09 PT PT98944379T patent/PT1025094E/pt unknown
- 1998-09-09 ES ES98944379T patent/ES2224429T3/es not_active Expired - Lifetime
- 1998-09-09 WO PCT/SE1998/001605 patent/WO1999014207A1/en active IP Right Grant
- 1998-09-09 US US09/171,575 patent/US6548498B1/en not_active Expired - Fee Related
- 1998-09-09 AT AT98944379T patent/ATE274502T1/de not_active IP Right Cessation
- 1998-09-09 DE DE69825912T patent/DE69825912T2/de not_active Expired - Fee Related
- 1998-09-09 CA CA002303839A patent/CA2303839A1/en not_active Abandoned
- 1998-09-09 EP EP98944379A patent/EP1025094B1/en not_active Expired - Lifetime
- 1998-09-09 AU AU91934/98A patent/AU734583B2/en not_active Ceased
- 1998-09-09 JP JP2000511758A patent/JP4020183B2/ja not_active Expired - Fee Related
-
2003
- 2003-01-09 US US10/339,477 patent/US20030144291A1/en not_active Abandoned
-
2004
- 2004-03-24 US US10/807,918 patent/US20050096326A1/en not_active Abandoned
-
2006
- 2006-10-03 US US11/543,250 patent/US7439356B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6548498B1 (en) | 2003-04-15 |
US20070149545A1 (en) | 2007-06-28 |
JP4020183B2 (ja) | 2007-12-12 |
ES2224429T3 (es) | 2005-03-01 |
DE69825912T2 (de) | 2005-09-01 |
EP1025094B1 (en) | 2004-08-25 |
AU9193498A (en) | 1999-04-05 |
PT1025094E (pt) | 2004-12-31 |
US20050096326A1 (en) | 2005-05-05 |
EP1025094A1 (en) | 2000-08-09 |
DE69825912D1 (de) | 2004-09-30 |
AU734583B2 (en) | 2001-06-14 |
JP2001516752A (ja) | 2001-10-02 |
US20030144291A1 (en) | 2003-07-31 |
CA2303839A1 (en) | 1999-03-25 |
US7439356B2 (en) | 2008-10-21 |
ATE274502T1 (de) | 2004-09-15 |
WO1999014207A1 (en) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9703379D0 (sv) | New compounds | |
ES2167371T3 (es) | Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos. | |
LU91196I2 (fr) | Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO). | |
TR200000736T2 (tr) | İkame edilmiş kroman türevleri. | |
EP0259255A3 (en) | Phenolic corrosion inhibitors for paints | |
ATE361283T1 (de) | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten | |
ATE9474T1 (de) | Cephalosporinverbindungen und ihre herstellung. | |
DE69434198D1 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten | |
NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
SE8003821L (sv) | Nya 3-aminovinylcefalosporiner och forfarande for framstellning derav | |
ES2038166T3 (es) | Procedimiento para preparar un derivado de indenotiazol. | |
DE60003140D1 (de) | Kosmetische photoschutzzusammenstellungen enthaltende Aminoamidine Derivate und Verwendungen | |
NZ337362A (en) | Heterocyclically substituted piperidyl-amino-indan-1-ol compounds and uses thereof | |
ECSP055652A (es) | Un nuevo proceso para la preparación de derivados de epotilona, nuevos derivados de epotilona, así como nuevos productos intermediarios para el proceso, y los métodos para su preparación | |
SE8405430L (sv) | 7-acylindolforeningar, lempade som mellanprodukter vid synteser av 7-acylindolin-2-oner | |
SE8005493L (sv) | 4-(haftalenyloxi)piperidin-derivat | |
DE69002340T2 (de) | Pyrimidin-Derivate, 2-[4-(Alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl] mit serotoninergischer Wirkung. | |
SE7707445L (sv) | Organiska foreningar, deras framstellning och anvendning | |
HU912140D0 (en) | Fungicide preparations containing benzyl-ketones and process for the production of the active agents | |
CO4370120A1 (es) | Tintas reactivas diazo, procesos para su preparacion y usos . | |
DK0555481T3 (da) | Tri(C1-C6-alkoxy)benzenderivat. | |
FI933205A (sv) | Tiazoletanolderivat, förfarande för deras framställning och deras mellanprodukter | |
FI871984A (fi) | 3-aminodihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
DK83183A (da) | N-hetero-cyclyl-4-piperidinaminer | |
ATE17490T1 (de) | Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. |